Kimberley Hacquoil

Prevalence, Risk Factors, Clinical Consequences, and Treatment of Enteral Feed Intolerance During Critical Illness

Usha Gungabissoon, Kimberley Hacquoil, Chanchal Bains et al. · Journal of Parenteral and Enteral Nutrition · 2014 · 285 citations

The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial

Marianne J. Chapman, Adam M. Deane, Stephanie O’Connor et al. · Critical Care · 2016 · 43 citations · Full text

The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying

Per M. Hellström, Jan Tack, Lakshmi Vasist Johnson et al. · British Journal of Pharmacology · 2016 · 38 citations · Full text

The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial

Ruth M. Hobson, Adam D. Farmer, Odile Dewit et al. · Neurogastroenterology & Motility · 2015 · 23 citations

Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double‐Blind, Placebo‐Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE Study

Adam M. Deane, François Lamontagne, George E. Dukes et al. · Journal of Parenteral and Enteral Nutrition · 2017 · 23 citations